Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,678
Total Claims
$1.2M
Drug Cost
606
Beneficiaries
$1,958
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-80%
Opioid rate vs peers
0.5% vs 2.6% avg
+83%
Cost per patient vs peers
$1,958 vs $1,068 avg
+64%
Brand preference vs peers
14.8% vs 9.0% avg
Opioid Prescribing
0.5%
Opioid Rate
56
Opioid Claims
$861
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,558 claims · $1.0M
Generic: 8,995 claims · $173K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 82 | $91K |
| Apixaban | 94 | $85K |
| Budesonide/Formoterol Fumarate | 122 | $58K |
| Insulin Detemir | 49 | $49K |
| Fluticasone/Umeclidin/Vilanter | 57 | $46K |
| Semaglutide | 43 | $45K |
| Insulin Aspart | 39 | $39K |
| Aripiprazole | 12 | $35K |
| Dulaglutide | 21 | $33K |
| Fluticasone/Vilanterol | 55 | $33K |
| Insulin Glargine,hum.Rec.Anlog | 29 | $33K |
| Mirabegron | 38 | $32K |
| Insulin Degludec | 21 | $32K |
| Tirzepatide | 28 | $31K |
| Risperidone Microspheres | 11 | $28K |
Prescribing Profile
Patient Profile
69
Avg Age
61%
Female
1.37
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About